A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5

doi:10.1016/0042-6822(88)90302-9

Virology

Volume 163, Issue 2, April 1988, Pages 614-617

https://doi.org/10.1016/0042-6822(88)90302-9 Get rights and content

Abstract

Early region 1 (E1) of the human adenoviruses has many intriguing properties which have prompted numerous mutational studies to help delineate and characterize the domains responsible for these functions. In mutational analyses being done currently, the El region is usually cloned into a bacterial plasmid where it is mutated and then the altered El sequences are “rescued” back into infectious virus. The most frequently used rescue procedures are somewhat tedious, requiring the purification and fractionation of linear viral DNA or DNA fragments, and often involve the screening of numerous plaque isolates. Several observations we have made recently on the properties of adenovirus DNA in infected cells and on infectious plasmids in transfected cells led us to design a new approach for rescuing E1 mutations into infectious viral genomes. We constructed a plasmid, pJM17, containing the entire Ad5 DNA molecule, with an insert in the El region that exceeds the packaging constraints of the adenovirus capsid. Following transfection of pJM17 into 293 cells the plasmid DNA is able to replicate but cannot be packaged into infectious virions. In contrast cotransfection of 293 cells with pJM17 plus an E1-containing plasmid carrying mutated sequences produces recombinant virions at high efficiencies. Neither plasmid needs to be linearized prior to cotransfection. The technique eliminates the need to purify and manipulate infectious virion DNA and since no unique restriction sites are needed, both ElA and E1 B mutants as well as foreign gene inserts in the E1 region can be easily rescued into virus.

References (25)

P.J. van den Elsen et al.
Gene
(1982)
E. Moran et al.
Cell
(1987)
J.W. Lillie et al.
Cell
(1986)
G. Ghosh-Choudhury et al.
Gene
(1986)
C. Thummel et al.
Cell
(1981)
C. Thummel et al.
Cell
(1983)
F.L. Graham et al.
Virology
(1973)
P.E. Branton et al.
Biochim. Biophys. Acta
(1985)
A.I. Berk
Cancer Surveys
(1986)
H.E. Ruley
Nature (London)
(1983)

E. Borrelli et al.

Nature (London)

(1984)

N.D. Stow

J. Virol.

(1981)

Cited by (570)

The structural reconformation of peptides in enhancing functional and therapeutic properties: Insights into their solid state crystallizations
2021, Biophysical Chemistry
Citation Excerpt :
Some attentions would be given in formulating different copolymer gels more focusing on the penetrative nano-targeted gels, signaling gels, covalence gels and therapeutic gels. Shimabukuro et al. [75] made significant efforts in evidencing the depletion of lipids or TAGs via gene amplification by encoding viral genes to leptin into form of AdCMV–leptin [76,77]. The results of hyper leptinemic were carried out into model rats chronically infused by plasma leptin along seven days.
Therapeutic peptides derived proteins with alpha-reconformation states like antibody shape have shown potential effects in combating terrible diseases linked with earlier signs of angiogensis, mutagenesis and transgenesis. Alpha reconformation in material design refers to the folding of the peptide chains and their transitions under reversible chemical bonds of disulfide chemical bridges and further non-covalence lesions. Thus, the rational design of signal peptides into alpha-helix is intended in increasing the defending effects of peptides into cores like adjuvant antibiotic and/or vaccines. Thereby, the signal peptides are able in displaying multiple eradicating regions by changing crystal-depositions and deviation angles. These types of molecular structures could have multiple advantages in tracing disease syndromes and impurities by increasing the host defense against the fates of pathogens and viruses, eventually leading to the loss in signaling by increasing peptide susceptibility levels to folding and unfolding and therefore, formation of transgenic peptide models. Alpha reconformation peptides is aimed in triggering as well as other regulatory functions such as remodulating metabolic chain disorders of lipolysis and glucolysis by increasing the insulin and leptin resistance for best lipid storages and lipoprotein density distributions.
Novel approaches for vaccine development
2021, Cell
Vaccines are critical tools for maintaining global health. Traditional vaccine technologies have been used across a wide range of bacterial and viral pathogens, yet there are a number of examples where they have not been successful, such as for persistent infections, rapidly evolving pathogens with high sequence variability, complex viral antigens, and emerging pathogens. Novel technologies such as nucleic acid and viral vector vaccines offer the potential to revolutionize vaccine development as they are well-suited to address existing technology limitations. In this review, we discuss the current state of RNA vaccines, recombinant adenovirus vector-based vaccines, and advances from biomaterials and engineering that address these important public health challenges.
ProT-α gene transfer attenuates cardiopulmonary remedying and mortality in a flow-induced pulmonary hypertension rat model
2020, Journal of Heart and Lung Transplantation
ProT is a cell survival gene, which modulates oxidative stress and transforming growth factor (TGF)-β signaling. We hypothesized that the delivery of the ProT cDNA gene in rats could protect against right heart dysfunction secondary to pulmonary hypertension (PH) induced by left-to-right shunt.
A 2-hit rat model of flow-induced PH was used, and a single intravenous injection of adenoviral vectors (2 billion plaque-forming unit) carrying ProT or Luc gene was administered. The animals were euthanized 21 days after gene delivery to assess cardiopulmonary function, serum biochemistry, pulmonary artery (PA), and vasomotor reactivity. Immunohistology and immunoblotting of PA tissues were also performed.
ProT transduction significantly reduced PA pressure, right ventricle muscle mass, and wall stress, thereby improving the overall survival of the treated rat. Increased production of ProT through gene therapy preserved both the smooth muscle myosin heavy chain-II and α-smooth muscle actin while counteracting the abundance of TGF-β in PA. Protein abundances of phosphorylated p47-phox, heme oxygenase-1, caspase-3, inducible nitric oxide synthase, cyclo-oxygenase 2, and monocyte chemoattractant protein-1 in PA tissues were reduced. ProT also preserved microRNA-223, thereby suppressing the abundance of PARP-1, which is independent of hypoxia-inducible factor-1α signaling.
ProT gene transduction improved PA function by reducing oxidative stress, attenuating inflammation, and preserving the contractile phenotype of vascular smooth muscle cells. The modification of microRNA-223–associated downstream signaling through ProT transduction may play an important role in mitigating cardiopulmonary remodeling in flow-induced PH.
Adenoviral Vector Construction I: Mammalian Systems
2016, Adenoviral Vectors for Gene Therapy: Second Edition
Given the immense potential of recombinant adenoviruses (Ads) as therapeutics for cancer and other genetic disorders, a huge effort has been made in improving the construction and propagation of Ad vectors. This chapter will focus on developments made in the construction and propagation of first generation adenoviral vectors in mammalian cells. The “two-plasmid rescue system” is one of the earliest methods and is still considered the method of choice for the construction of Ad vectors, although it has gone through many refinements. This chapter will walk the readers through development of the two-plasmid rescue system for efficient construction of Ad vectors. Moreover, this chapter discusses different strategies for the construction and propagation of Ad vectors encoding toxic genes that are often troublesome to rescue. Finally, developments in the construction process for generating Ad-based human cDNA libraries are also discussed.
Filling the Immunological Gap: Recombinant Viral Vectors for Mucosal Vaccines
2015, Mucosal Immunology: Fourth Edition
Most pathogens initiate infection via mucosal routes; consequently effective vaccines that induce relevant innate and adaptive immune responses at mucosal sites are required for protection. Indeed, we are confronted by a number of major global infections, such as HIV and tuberculosis, that have complex methods of pathogenesis, that can be antigenically diverse, and that evolved significant mechanisms to evade human immune responses. The challenge for producing vaccines against these agents is knowing the type of immune responses critical for control of infection. The use of recombinant viral vectors provides a novel approach for delivering genes encoding antigens of a different pathogen as a vaccine. Here we aim to provide an overview of recombinant viral vectors that can be utilized for mucosal immunization and a current review of outcomes of human trials involving these viral vectors. Although RV144 was marginally effective, there were also setbacks in HIV vaccine trials involving Ad5 vectors. Importantly, exciting progress has been made in identification of novel vectors that induce local mucosal control of early infection and significantly improve the breadth of T cell-mediated responses. Indeed, findings concerning local mucosal control of HIV and TB are merging into a comparable storyline that may offer control of these pathogens.
Enhanced growth of recombinant human Adenovirus type 41 (HAdV-41) carrying ADP gene
2013, Virus Research
Human adenovirus type 41 (HAdV-41) has the potential to be constructed as a gene transfer vector for oral vaccine or gene therapy targeting gastrointestinal tract. Block in release of progeny virus from host cell severely affects the yield during virus amplification. In this study, HAdV-5 adenovirus death protein (ADP) gene was used to replace the open reading frames (ORFs) of the HAdV-41 E3 region to construct a backbone plasmid pAdbone41ADP. Recombinant adenoviral plasmids harboring ADP and GFP genes (pAd41ADP–GFP) were generated. Plaques were formed and HAdV-41-ADP–GFP virus was rescued after transfecting pAd41ADP–GFP into the packaging cell line 293TE32. When amplified on 293TE32 cells, HAdV-41-ADP–GFP virus released to the culture medium was 10–50 times more than control virus HAdV-41-GFP, which did not carry ADP gene. The results demonstrated that incorporation of the ADP gene substantially increased the yield of recombinant HAdV-41 virus through enhancing spread of progeny virus among packaging cells.

View all citing articles on Scopus

View full text

Short communicationA simple technique for the rescue of early region I mutations into infectious human adenovirus type 5

Abstract

Gene

Cell

Cell

Gene

Cell

Cell

Virology

Biochim. Biophys. Acta

Cancer Surveys

Nature (London)

Nature (London)

J. Virol.

Short communication
A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5